Fundamental that for grant of patent the subject must satisfy ...
Supreme Court Rules Beta Crystalline Form of Imatinib Mesylate Ineligible for Patent Due to Non-Patentability.
April 16, 2013
Case Laws Indian Laws SC
Fundamental that for grant of patent the subject must satisfy the twin tests of “invention” and “patentability” - the beta crystalline form of Imatinib Mesylate, fails in both the tests of invention and patentability - SC
View Source